Minocycline
In clinical developmentAlso known as Amzeeq, Arestin, Cleeravue-M, Dynacin+15 more
Amzeeq, Arestin, Cleeravue-M, Dynacin, Emrosi, Minociclinum, Minocin, Minolira, Myrac, Solodyn, Vectrin, Ximino, Zilxi, 7-Dimethylamino-6-demethyl-6-deoxytetracycline, Minociclina, Minocyclin, (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, Minocycline Hydrochloride, Minocyclinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
Stony Brook Medicine Anti-Inflammatory Trial
Guidelines of care for the management of acne vulgaris.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Stony Brook Medicine Anti-Inflammatory Trial
A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- The Journal of neuroscience : the official journal of the Society for Neuroscience3
- Journal of neuroinflammation2
- Stroke2
- BMC neurology1
- Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie1
- Investigative ophthalmology & visual science1
- Wong WT4
- Chew EY3
- Cukras CA3
- Abraham M2
- Arunachalam T2
- Bailey C2
- Bellur S2
- Edwards DJ2
- National Eye Institute3
- Bristol Eye Hospital2
- University of California2
- American Academy of Dermatology1
- Beth Israel Deaconess Medical Center1
- Brigham and Women's Hospital1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Minocycline in the shared literature.
Studied across 3 of the same disease areas as Minocycline in the shared literature.
Studied across 3 of the same disease areas as Minocycline in the shared literature.
Studied across 2 of the same disease areas as Minocycline in the shared literature.
Studied across the same disease area as Minocycline in the shared literature.
Studied across the same disease area as Minocycline in the shared literature.
Studied across the same disease area as Minocycline in the shared literature.
Studied across the same disease area as Minocycline in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials